Sleiman, S. F., Langley, B. C., Berlin, J., Xia, L., Payappilly, J. B., Kharel, M. K., . . . Ratan, R. R. (2011). Mithramycin is a gene-selective Sp1 inhibitor that identifies a biological intersection between cancer and neurodegeneration.
توثيق أسلوب شيكاغو (الطبعة السابعة عشر)Sleiman, Sama F., et al. Mithramycin Is a Gene-selective Sp1 Inhibitor That Identifies a Biological Intersection Between Cancer and Neurodegeneration. 2011.
توثيق جمعية اللغة المعاصرة MLA (الإصدار التاسع)Sleiman, Sama F., et al. Mithramycin Is a Gene-selective Sp1 Inhibitor That Identifies a Biological Intersection Between Cancer and Neurodegeneration. 2011.
تحذير: قد لا تكون هذه الاستشهادات دائما دقيقة بنسبة 100%.